Stimulation of glycosaminoglycan synthesis in cultured human dermal fibroblasts by interleukin 1. Induction of hyaluronic acid synthesis by natural and recombinant interleukin 1s and synthetic interleukin 1 beta peptide 163-171.

PubWeight™: 1.11‹?› | Rank: Top 10%

🔗 View Article (PMC 303724)

Published in J Clin Invest on February 01, 1989

Authors

A E Postlethwaite1, G N Smith, L B Lachman, R O Endres, H M Poppleton, K A Hasty, J M Seyer, A H Kang

Author Affiliations

1: Laboratory of Cellular Immunology, Veterans Administration Medical Center, Memphis, Tennessee.

Articles citing this

Hyaluronate activation of CD44 induces insulin-like growth factor-1 expression by a tumor necrosis factor-alpha-dependent mechanism in murine macrophages. J Clin Invest (1993) 1.82

20S-hydroxyvitamin D3, noncalcemic product of CYP11A1 action on vitamin D3, exhibits potent antifibrogenic activity in vivo. J Clin Endocrinol Metab (2013) 1.17

Cytokine regulation of human lung fibroblast hyaluronan (hyaluronic acid) production. Evidence for cytokine-regulated hyaluronan (hyaluronic acid) degradation and human lung fibroblast-derived hyaluronidase. J Clin Invest (1992) 1.11

Vitamin D analogs 17,20S(OH)2pD and 17,20R(OH)2pD are noncalcemic and exhibit antifibrotic activity. J Invest Dermatol (2011) 1.08

Fibroblast chemotaxis induction by human recombinant interleukin-4. Identification by synthetic peptide analysis of two chemotactic domains residing in amino acid sequences 70-88 and 89-122. J Clin Invest (1991) 1.01

Stimulation of fibroblast chemotaxis by human recombinant tumor necrosis factor alpha (TNF-alpha) and a synthetic TNF-alpha 31-68 peptide. J Exp Med (1990) 0.98

Dermatomyositis. Curr Dir Autoimmun (2008) 0.91

Upregulation of fibronectin synthesis by interleukin-1 beta in coronary artery smooth muscle cells is associated with the development of the post-cardiac transplant arteriopathy in piglets. J Clin Invest (1993) 0.90

Pathogenesis of Systemic Sclerosis. Front Immunol (2015) 0.89

Interferon-gamma stimulates the secretion of IL-1, but not of IL-6, by glomerular mesangial cells. Clin Exp Immunol (1993) 0.82

Inflammatory alterations of the extracellular matrix in the tumor microenvironment. Cancers (Basel) (2011) 0.81

Gadolinium-based compounds induce NLRP3-dependent IL-1β production and peritoneal inflammation. Ann Rheum Dis (2014) 0.80

Identification of specific chondroitin sulfate species in cutaneous autoimmune disease. J Histochem Cytochem (2011) 0.79

Prostaglandin E2 stimulates cyclic AMP-mediated hyaluronan synthesis in rabbit pericardial mesothelial cells. Biochem J (1993) 0.78

Interleukin-1 beta-induced changes in the kinetic constants of L-proline uptake in human skin fibroblasts. Biochem J (1991) 0.76

Interleukin-1 beta regulation of fibroblast proteoglycan synthesis involves a decrease in versican steady-state mRNA levels. Biochem J (1993) 0.75

Articles cited by this

A protein sequenator. Eur J Biochem (1967) 17.03

The fluorometric measurement of deoxyribonucleic acid in animal tissues with special reference to the central nervous system. J Biol Chem (1958) 11.74

Interleukin-1. Rev Infect Dis (1984) 11.24

Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs. Nature (1985) 9.94

Interleukin 1, a potential regulator of fibroblast proliferation. J Immunol (1982) 6.05

Stimulation of rheumatoid synovial cell collagenase and prostaglandin production by partially purified lymphocyte-activating factor (interleukin 1). Proc Natl Acad Sci U S A (1981) 4.89

Participation of monocyte-macrophages and lymphocytes in the production of a factor that stimulates collagenase and prostaglandin release by rheumatoid synovial cells. J Clin Invest (1979) 3.34

The chemotactic attraction of human fibroblasts to a lymphocyte-derived factor. J Exp Med (1976) 3.04

Detection and characterization of high affinity plasma membrane receptors for human interleukin 1. J Exp Med (1985) 3.00

Properties of a specific interleukin 1 (IL 1) receptor on human Epstein Barr virus-transformed B lymphocytes: identity of the receptor for IL 1-alpha and IL 1-beta. J Immunol (1986) 2.49

Interleukin 1 stimulation of collagenase production by cultured fibroblasts. J Exp Med (1983) 2.28

Studies on the location of intermolecular cross-links in collagen. Isolation of a CNBr peptide containing -hydroxylysinonorleucine. Biochemistry (1972) 2.25

Epithelial collagens and glycosaminoglycans in the embryonic cornea. Macromolecular order and morphogenesis in the basement membrane. J Cell Biol (1974) 2.18

Multiple biological activities of human recombinant interleukin 1. J Clin Invest (1986) 2.16

Human interleukin 1: purification and properties. Fed Proc (1983) 2.12

FINE STRUCTURES OF THE SYNOVIAL TISSUES IN RHEUMATOID ARTHRITIS. Kobe J Med Sci (1964) 1.98

Identification of a specific interleukin 1 inhibitor in the urine of febrile patients. J Exp Med (1984) 1.90

Biosynthesis of tissue inhibitor of metalloproteinases by human fibroblasts in culture. Stimulation by 12-O-tetradecanoylphorbol 13-acetate and interleukin 1 in parallel with collagenase. J Biol Chem (1985) 1.86

Synergistic stimulation of fibroblast prostaglandin production by recombinant interleukin 1 and tumor necrosis factor. J Immunol (1987) 1.73

The extracellular matrix of the regenerating newt limb: synthesis and removal of hyaluronate prior to differentiation. Dev Biol (1971) 1.60

Modulation of fibroblast functions by interleukin 1: increased steady-state accumulation of type I procollagen messenger RNAs and stimulation of other functions but not chemotaxis by human recombinant interleukin 1 alpha and beta. J Cell Biol (1988) 1.58

Modulation by recombinant interleukin 1 of synthesis of types I and III collagens and associated procollagen mRNA levels in cultured human cells. J Biol Chem (1987) 1.51

Synovial membrane in traumatic effusion. Ultrastructure and autoradiography with tritiated leucine. Ann Rheum Dis (1966) 1.44

Induction of fibroblast proliferation by interleukin-1 derived from human monocytic leukemia cells. Arthritis Rheum (1984) 1.36

A short synthetic peptide fragment of human interleukin 1 with immunostimulatory but not inflammatory activity. J Immunol (1986) 1.30

Hyaluronate in morphogenesis: inhibition of chondrogenesis in vitro. Proc Natl Acad Sci U S A (1972) 1.24

Developmental role of hyaluronate. Connect Tissue Res (1982) 1.23

Identification of a high-affinity receptor for native human interleukin 1 beta and interleukin 1 alpha on normal human lung fibroblasts. J Exp Med (1987) 1.21

Interleukin 1 enhances synovial cell hyaluronate synthesis. Proc Soc Exp Biol Med (1984) 1.14

Analysis of glycosaminoglycans within the extracellular environments encountered by migrating neural crest cells. Dev Biol (1978) 1.14

Uromodulin. An immunosuppressive 85-kilodalton glycoprotein isolated from human pregnancy urine is a high affinity ligand for recombinant interleukin 1 alpha. J Biol Chem (1986) 1.11

Post-transcriptional inhibition of collagen and fibronectin synthesis by a synthetic homolog of a portion of the carboxyl-terminal propeptide of human type I collagen. J Biol Chem (1986) 1.10

Stimulation of fibroblast proliferation and prostaglandin production by purified recombinant murine interleukin 1. Clin Immunol Immunopathol (1986) 1.09

Interleukin 1 from human leukemic monocytes. Methods Enzymol (1985) 1.07

Molecular composition and origin of substrate-attached material from normal and virus-transformed cells. J Supramol Struct (1976) 1.03

The human fetal synovium. Histology, fine structure and changes in organ culture. Arthritis Rheum (1971) 0.99

Determination of sulphated disaccharides from chondroitin sulphates by high-performance liquid chromatography. J Chromatogr (1979) 0.99

Soluble mediators from mononuclear cells increase the synthesis of glycosaminoglycan by dermal fibroblast cultures derived from normal subjects and progressive systemic sclerosis patients. Arthritis Rheum (1985) 0.98

Human recombinant interleukin-1 beta stimulates glycosaminoglycan production in human synovial fibroblast cultures. Arthritis Rheum (1987) 0.93

Studies on glycosaminoglycans of regenerating rabbit ear cartilage. Dev Biol (1981) 0.89

The glycosaminoglycans of open wounds. J Surg Res (1980) 0.89

Angiotensin II-induced hypertension in the rat. Effects on the plasma concentration, renal excretion, and tissue release of prostaglandins. J Clin Invest (1983) 0.88

Ability of growth hormone fragments to complete with 125I-iodinated human growth hormone for specific binding to isolated adipocytes of hypophysectomized rats. Biochim Biophys Acta (1982) 0.83

Modulation of human lymphocyte response by cartilage proteoglycans and glycosaminoglycans--a comparison between normal subjects and patients with rheumatoid arthritis. Clin Immunol Immunopathol (1979) 0.80

Hyaluronidase activity and glycosaminoglycan synthesis in the amputated newt limb: comparison of denervated, nonregenerating limbs with regenerates. Dev Biol (1975) 0.80

The nature and origin of the glycosaminoglycans of the embryonic chick vitreous body. Dev Biol (1978) 0.78

Biosynthesis of glycosaminoglycans by epithelial and lymphocytic components of murine thymus. J Immunol (1983) 0.77

Articles by these authors

Autoimmunity to type II collagen an experimental model of arthritis. J Exp Med (1977) 10.09

The functional relationship of the interleukins. J Exp Med (1980) 5.62

Growth of a cloned helper T cell line induced by a monoclonal antibody specific for the antigen receptor: interleukin 1 is required for the expression of receptors for interleukin 2. J Immunol (1984) 5.51

Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta. J Exp Med (1987) 4.35

Is thrombophilia associated with placenta-mediated pregnancy complications? A prospective cohort study. J Thromb Haemost (2014) 3.90

Purification and properties of M protein extracted from group A streptococci with pepsin: covalent structure of the amino terminal region of type 24 M antigen. J Exp Med (1977) 3.62

Primary structure of protective antigens of type 24 streptococcal M protein. J Biol Chem (1980) 3.39

Type-specific protective immunity evoked by synthetic peptide of Streptococcus pyogenes M protein. Nature (1981) 3.38

Monocyte-conditioned medium, interleukin-1, and tumor necrosis factor stimulate the acute phase response in human hepatoma cells in vitro. J Cell Biol (1986) 3.20

Collagen-and collagen peptide-induced chemotaxis of human blood monocytes. J Exp Med (1976) 3.17

Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase. J Biol Chem (1985) 3.15

Type II collagen-induced arthritis in rats. Passive transfer with serum and evidence that IgG anticollagen antibodies can cause arthritis. J Exp Med (1982) 3.06

The chemotactic attraction of human fibroblasts to a lymphocyte-derived factor. J Exp Med (1976) 3.04

Chemotactic attraction of human fibroblasts to type I, II, and III collagens and collagen-derived peptides. Proc Natl Acad Sci U S A (1978) 3.00

Repeating covalent structure of streptococcal M protein. Proc Natl Acad Sci U S A (1978) 2.89

Humoral and cellular sensitivity to collagen in type II collagen-induced arthritis in rats. J Clin Invest (1978) 2.84

Preparation of lymphocyte-activating factor from continuous murine macrophage cell lines. Cell Immunol (1977) 2.81

Transforming growth factor-beta increases steady state levels of type I procollagen and fibronectin messenger RNAs posttranscriptionally in cultured human dermal fibroblasts. J Clin Invest (1987) 2.74

Induction of arthritis with monoclonal antibodies to collagen. J Immunol (1992) 2.64

Interleukin 1 of the central nervous system is produced by ameboid microglia. J Exp Med (1986) 2.62

Collagen polymorphism in idiopathic chronic pulmonary fibrosis. J Clin Invest (1976) 2.60

Partial purification of human lymphocyte-activating factor (LAF) by ultrafiltration and electrophoretic techniques. J Immunol (1977) 2.58

Interleukin-1 stimulation of astroglial proliferation after brain injury. Science (1985) 2.35

Nature and specificity of the immune response to collagen in type II collagen-induced arthritis in mice. J Clin Invest (1982) 2.29

Interleukin 1 stimulation of collagenase production by cultured fibroblasts. J Exp Med (1983) 2.28

Studies on the location of intermolecular cross-links in collagen. Isolation of a CNBr peptide containing -hydroxylysinonorleucine. Biochemistry (1972) 2.25

Collagen-induced arthritis, an animal model of autoimmunity. Life Sci (1997) 2.20

Lymphocyte modulation of fibroblast function in vitro: stimulation and inhibition of collagen production by different effector molecules. J Immunol (1984) 2.18

Collagen-induced arthritis in rats. Evaluation of early immunologic events. Arthritis Rheum (1979) 2.16

Isolation of two distinct collagens from chick cartilage. Biochemistry (1970) 2.14

Degradation of type IV (basement membrane) collagen by a proteinase isolated from human polymorphonuclear leukocyte granules. J Biol Chem (1980) 2.13

Human interleukin 1: purification and properties. Fed Proc (1983) 2.12

Collagen autoimmune arthritis. Annu Rev Immunol (1984) 2.10

Induction of fibroblast chemotaxis by fibronectin. Localization of the chemotactic region to a 140,000-molecular weight non-gelatin-binding fragment. J Exp Med (1981) 2.10

Reduction of the severity of canine osteoarthritis by prophylactic treatment with oral doxycycline. Arthritis Rheum (1992) 2.01

Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells. J Exp Med (1983) 1.99

Regulation of mRNAs for type-1 plasminogen activator inhibitor, fibronectin, and type I procollagen by transforming growth factor-beta. Divergent responses in lung fibroblasts and carcinoma cells. J Biol Chem (1988) 1.93

Localization of protective epitopes within the pilin subunit of the Vibrio cholerae toxin-coregulated pilus. Infect Immun (1991) 1.90

Osteoarthritic lesions: involvement of three different collagenases. Arthritis Rheum (1997) 1.90

An HLA-DR1 transgene confers susceptibility to collagen-induced arthritis elicited with human type II collagen. J Exp Med (1997) 1.89

Establishment by the rat lymph node method of epitope-defined monoclonal antibodies recognizing the six different alpha chains of human type IV collagen. Histochem Cell Biol (1995) 1.88

Collagen-induced arthritis in mice: synergistic effect of E. coli lipopolysaccharide bypasses epitope specificity in the induction of arthritis with monoclonal antibodies to type II collagen. Autoimmunity (1995) 1.85

Type-specific immunogenicity of a chemically synthesized peptide fragment of type 5 streptococcal M protein. J Exp Med (1983) 1.82

Abnormalities of myelination in schizophrenia detected in vivo with MRI, and post-mortem with analysis of oligodendrocyte proteins. Mol Psychiatry (2003) 1.79

Interleukin-1 injected into mammalian brain stimulates astrogliosis and neovascularization. J Neurosci (1988) 1.78

Repeating covalent structure and protective immunogenicity of native and synthetic polypeptide fragments of type 24 streptococcal M protein. Mapping of protective and nonprotective epitopes with monoclonal antibodies. J Biol Chem (1983) 1.73

Primary structural similarities between types 5 and 24 M proteins of Streptococcus pyogenes. Biochem Biophys Res Commun (1980) 1.72

Antigen recognition by T cells and B cells: recognition of cross-reactivity between native and denatured forms of globular antigens. Clin Immunol Immunopathol (1980) 1.72

Collagen-induced arthritis in rats. Comparison of vitreous and cartilage-derived collagens. Arthritis Rheum (1979) 1.71

Collagen polymorphism in normal and cirrhotic human liver. J Clin Invest (1977) 1.68

Epitope-specific protective immunogenicity of chemically synthesized 13-, 18-, and 23-residue peptide fragments of streptococcal M protein. Proc Natl Acad Sci U S A (1984) 1.67

Differential expression of two basement membrane collagen genes, COL4A6 and COL4A5, demonstrated by immunofluorescence staining using peptide-specific monoclonal antibodies. J Cell Biol (1995) 1.67

Coordinate production by a T cell hybridoma of gamma interferon and three other lymphokine activities: multiple activities of a single lymphokine? J Immunol (1983) 1.67

Interaction of lipoteichoic acid of group A streptococci with human platelets. Infect Immun (1977) 1.65

Characterization of the alpha-chains of chick skin collagen and the nature of the NH2-terminal cross-link region. Biochemistry (1969) 1.63

Characterization of the cyanogen bromide peptides from the alpha 1 chain of chick skin collagen. Biochemistry (1969) 1.63

Isolation and purification of collagen alpha 1(I) receptor from human platelet membrane. J Biol Chem (1982) 1.62

Coordinate regulation of transforming growth factor beta gene expression and cell proliferation in hamster lungs undergoing bleomycin-induced pulmonary fibrosis. J Clin Invest (1989) 1.62

Human T lymphocyte/monocyte interaction in response to lectin: kinetics of entry into the S-phase. J Immunol (1981) 1.62

The nature and location of intramolecular cross-links in collagen. Proc Natl Acad Sci U S A (1966) 1.60

Formation of multinucleated giant cells from human monocyte precursors. Mediation by a soluble protein from antigen-and mitogen-stimulated lymphocytes. J Exp Med (1982) 1.59

Studies on the structure of collagen utilizing a collagenolytic enzyme from tadpole. Biochemistry (1966) 1.59

Modulation of fibroblast functions by interleukin 1: increased steady-state accumulation of type I procollagen messenger RNAs and stimulation of other functions but not chemotaxis by human recombinant interleukin 1 alpha and beta. J Cell Biol (1988) 1.58

Evidence for cell-mediated immunity to collagen in progressive systemic sclerosis. J Lab Clin Med (1976) 1.57

Vascular endothelial growth factor increases release of gelatinase A and decreases release of tissue inhibitor of metalloproteinases by microvascular endothelial cells in vitro. Microvasc Res (1998) 1.55

Intraarticular injection of hyaluronan as treatment for knee osteoarthritis: what is the evidence? Arthritis Rheum (2000) 1.55

The amino acid sequence of peptides from the cross-linking region of rat skin collagen. Biochemistry (1967) 1.54

Protective and nonprotective epitopes of chemically synthesized peptides of the NH2-terminal region of type 6 streptococcal M protein. J Immunol (1986) 1.54

Collagen-induced arthritis in mice. Localization of an arthritogenic determinant to a fragment of the type II collagen molecule. J Exp Med (1985) 1.52

Incidence and specificity of antibodies to types I, II, III, IV, and V collagen in rheumatoid arthritis and other rheumatic diseases as measured by 125I-radioimmunoassay. Arthritis Rheum (1983) 1.51

Effect of interleukin 1 on human thymocytes and purified human T cells. J Exp Med (1981) 1.50

Collagen heterogeneity. High resolution separation of native ( 1(I) 2 2 and ( 1(II) 3 and their component chains. J Biol Chem (1972) 1.50

Specific cleavage of human type III collagen by human polymorphonuclear leukocyte elastase. J Biol Chem (1980) 1.50

Collagen-induced arthritis in rats: antigen-specific suppression of arthritis and immunity by intravenously injected native type II collagen. J Immunol (1983) 1.49

The collagen substrate specificity of human neutrophil collagenase. J Biol Chem (1987) 1.49

Identification of specific sites in the TNF-alpha molecule promoting insulin resistance in H-411E cells. J Lab Clin Med (1997) 1.49

Serum transfer of collagen-induced arthritis. II. Identification and localization of autoantibody to type II collagen in donor and recipient rats. Arthritis Rheum (1983) 1.48

Characterization of the cyanogen bromide peptides from the alpha-2 chain of chick skin collagen. Biochemistry (1969) 1.46

Subcellular localization of human monocyte interleukin 1: evidence for an inactive precursor molecule and a possible mechanism for IL 1 release. J Immunol (1987) 1.44

Expression of a metalloproteinase that degrades native type V collagen and denatured collagens by cultured human alveolar macrophages. J Clin Invest (1987) 1.43

Collagen-induced polyarthritis in rats: a study of native type II collagen for adjuvant activity. J Immunol (1980) 1.43

Uptake of IgG after intramuscular and subcutaneous injection. Lancet (1972) 1.42

Processing of TCP pilin by TcpJ typifies a common step intrinsic to a newly recognized pathway of extracellular protein secretion by gram-negative bacteria. Genes Dev (1991) 1.40